Claritin Hives Relief Reditab

   
Google
 
Web NewDrugInformation.com

Claritin Hives Relief Reditab


Drug - Claritin Hives Relief Reditab
The trade name of the product as shown on the labeling.

Dosage - TABLET, ORALLY DISINTEGRATING; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Loratadine
Multiple ingredients are in alphabetical order.

Strength - 10MG
The potency of the active ingredient(s), Loratadine. May repeat for multiple part products.

Applicant - SCHERING PLOUGH
The firm name holding legal responsibility for Claritin Hives Relief Reditab. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020704
The FDA assigned number to Claritin Hives Relief Reditab. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Claritin Hives Relief Reditab. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 19, 2003
The date Claritin Hives Relief Reditab was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Claritin Hives Relief Reditab. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - OTC
The group or category of approved drugs Claritin Hives Relief Reditab is in. Format is RX, OTC, DISCN.

Applicant Full Name - Schering Plough Healthcare Products Inc
The full name of the firm holding legal responsibility for the new application of Claritin Hives Relief Reditab.

Claritin Hives Relief Reditab